(Stroke. 2000;31:86.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Emergency Medicine (A.Z., M.H., F.S., W.B., W.S., M.M., A.N.L.), Intensive Care Units, Departments of Internal Medicine (1st [M.F.], 2nd [P.S.] and 4th [K.R.]), Medical School, University of Vienna, and Vienna Ambulance Service (A.K.), City of Vienna, Austria.
Correspondence to Dr med Fritz Sterz, AKH-Notfallaufnahme, Waehringerguertel 18-20/6/D, 1090 Wien, Austria. E-mail Fritz.Sterz{at}AKH-Wien.ac.at
| Abstract |
|---|
|
|
|---|
MethodsWe lowered patients temperature after admission to the emergency department and continued cooling for at least 24 hours after arrest in conjunction with advanced cardiac life support. The cooling technique chosen was external head and total body cooling with a cooling device in conjunction with a blanket and a mattress. Infrared tympanic thermometry was monitored before a central pulmonary artery thermistor probe was inserted.
ResultsIn 27 patients (age 58 [interquartile range [IQR] 52 to 64] years; 7 women; estimated "no-flow" duration 6 [IQR 1 to 11] minutes and "low-flow" duration 15 [IQR 9 to 23] minutes; admitted to the emergency department 36 [IQR 24 to 43] minutes after return of spontaneous circulation), we could initiate cooling within 62 (IQR 41 to 75) minutes and achieve a pulmonary artery temperature of 33±1°C 287 (IQR 42 to 401) minutes after cardiac arrest. During 24 hours of mild resuscitative hypothermia, no major complications occurred. Passive rewarming >35°C was accomplished within 7 hours.
ConclusionsMild resuscitative hypothermia in patients is feasible and safe. A clinical multicenter trial might prove that mild hypothermia is a useful method of cerebral resuscitation after global ischemic states.
Key Words: cardiopulmonary resuscitation heart arrest hypothermia outcome
| Introduction |
|---|
|
|
|---|
The ability of tissue to survive anoxic no-flow states is drastically reduced in normothermia compared with hypothermia.3 4 Hypothermia is "a state of body temperature which is below normal in a homeothermic organism."5 Accidental hypothermia is nontherapeutically altered body temperature associated with particular complications and requiring specific treatments.6 The efficacy of hypothermia in preserving neurological function when instituted before and during certain no-flow cardiovascular states has been well documented both clinically and experimentally in dog outcome models since the 1950s.3 7 8 9 10 11 12 13 Recently, mild hypothermia (34°C) was discovered to mitigate brain damage significantly when induced before,3 during, or after cardiac arrest.14 15
A recently initiated European multicenter trial aims to investigate the effect of mild resuscitative hypothermia for a duration of 24 hours on cerebral recovery in humans after cardiac arrest. A preliminary trial was conducted to evaluate safety and feasibility of mild resuscitative hypothermia after cardiac arrest.16 17
| Subjects and Methods |
|---|
|
|
|---|
Patients
From April 1995 to January 1996 prospectively, we
analyzed Utstein-style18 collected data of
consecutive patients admitted to the Department of Emergency Medicine
at the University Hospital after prehospital cardiac arrest. Included
were adults with witnessed, nontraumatic, normothermic
cardiac arrest of presumed cardiac origin. To exclude the influence of
the initial rhythm on patients medical management and
outcome,19 20 21 we focused on patients with
ventricular fibrillation as the initial ECG pattern
recorded by the emergency medical team in the field. Cardiac arrest
was defined as the absence of both spontaneous respiration and palpable
pulses. Patients were excluded if the duration of cardiac arrest was
<5 or >15 minutes and if primary cardiopulmonary
resuscitation failed to achieve any return of spontaneous circulation
within 60 minutes. Any return of spontaneous circulation was defined as
the appearance of a palpable arterial pulse for >5
minutes. Furthermore, we excluded patients with known malignancy,
pregnancy, and unfavorable overall or cerebral performance
before cardiac arrest,22 23 24 those with evidence of
additional ischemic damage (prolonged [>30 minutes]
hypotension [mean arterial pressure <60 mm Hg] or
prolonged [>15 minutes] hypoxia [oxygen saturation
<0.85]) to the brain before the experimental therapy was initiated,
and those who had an additional cardiac arrest within 6 months after
the primary event.
The interval from the time of collapse (presumed time of cardiac arrest) to basic and/or advanced life support was defined as no-flow duration, and the interval from the beginning of life support until the return of spontaneous circulation or termination of resuscitative efforts was termed low-flow duration. Data were obtained through interviews with the ambulance physicians, paramedics, bystanders, and families. The recording of periods of time during cardiac arrest is an estimate and cannot be quantified accurately. Owing to the fact that only 1 person was responsible for collecting the patients charts according to the Utstein style of collecting data,18 highly accurate data were available for every patient. Because witnesses were personally interviewed, imprecision surrounding the exact time of recognition of collapse and the accurate time of the emergency medical activation was minimized.
General Management
Acute care included basic and advanced cardiac life support
performed by the ambulance service personnel or in-hospital emergency
medical technicians and physicians per standard protocol.1
In the emergency department, after initial neurological evaluation and
assessment of respiratory and hemodynamic function, the
patient was provided with standardized treatment as described below.
Eligibility for the study was assessed as soon as possible at the
hospital. Standard medical management of all patients required Foley
catheters, arterial catheters, central venous catheters,
and intubation. Sedation and analgesia were performed with midazolam
and fentanyl, titrated for 32 hours to facilitate respiratory
management and to avoid stress induced by invasive procedures.
Relaxation was done by neuromuscular blockade with pancuronium for 32
hours. The lowest dose that would permit complete muscle relaxation was
used. Neuromuscular relaxants are essential to maintain hypothermia and
to prevent shivering with a subsequent rise in the systemic and
cerebral metabolic rates.25 26 Ventilators
were set to maintain an arterial oxygen saturation of
>0.95 with PaO2 between 100 and
150 mm Hg and PaCO2 between 40
and 45 mm Hg. Arterial pH was kept between 7.37 and
7.45 by use of
-stat management (temperature-uncorrected
PaO2 and pH).27 28
Positive end-expiratory pressure <5 mm Hg was used carefully to
reduce FIO2. Mean
arterial blood pressure was kept >60 mm Hg, and
decreases in systemic blood pressure were treated primarily with
crystalloid fluids or hydroxyl ethyl starch. Vasopressors such as
epinephrine, norepinephrine, dopamine, and
dobutamine were used if sufficient blood pressure control
could not be achieved with fluids alone. Fluid balance was controlled;
neither dextrose nor free water was given, to avoid generation of
cerebral edema. To minimize hyperglycemia, no glucose was used in
intravenous fluids. Serum blood glucose was kept between
5.5 and 11.1 mmol/L (100 and 200 mg/dL) and hematocrit between
0.30 and 0.45. Potassium was supplemented if the serum potassium level
was <4 mmol/L. Thrombolytic therapy was given as
indicated. Parenteral nutrition or enteric feeding was begun as soon as
practical. Maintenance of fluid and electrolyte homeostasis was
a standard requirement, and monitoring was performed either by
pulmonary artery catheterization or by
evaluation of fluid intake and output. Optimal head position (30°)
was provided, and movements of the head were done carefully to avoid
too much torsion and flexion of the neck. Laboratory studies were
performed as clinically indicated. Brain death was determined and
certified according to legally and ethically accepted
methods.29 Life support was maintained for
3 days in all
except certified brain-dead patients. In all patients who responded to
pain in any manner, life support was maintained for
7 days.
Temperature Management and Cooling Procedures
The target temperature was a core temperature of 33±1°C,
which was defined as mild resuscitative hypothermia and which has shown
benefit in former and recent prospective, randomized, controlled human
trials.30 31 32 33 This low core temperature was achieved by
external head and body cooling. Through a water-circulating system
(Plastipads, Cincinnati Sub-Zero Products, Inc), fluid flowed
through the blankets and the temperature-controlling device (Blanketrol
II Hypothermia System, Cincinnati Sub-Zero Products, Inc). The
blankets were placed within a special mattress consisting of air
cushions (TheraKair, Kinetic Concepts, Inc), which avoided direct
patient contact with the blankets. Air, which was now temperature
controlled by the blankets, flowed in alternating cushions to avoid
constant cooling of one part of the patients body, eg, a skin
segment. In addition, head and body cooling was performed with a
lightweight mattress with tiny holes (Bair Hugger Blanket, Augustin
Medical, Inc) with constant cold air flow (Polar Bair, Augustin
Medical, Inc). Active cooling was started immediately on arrival of the
patient at the emergency department by placing the patient on the
precooled mattress. Active cooling was stopped 24 hours after arrival
in the emergency department. The period of 24 hours was thought to be a
compromise of minimum time needed to achieve a
benefit34 35 and maximum time tolerated for possible side
effects.36 No active external rewarming procedures were
performed.
Temperature was primarily monitored and controlled with intermittent infrared tympanic thermometry measurements (Ototemp LighTouch, Exergen Corporation). LighTouch models accurately measure arterial temperature via heat balance at the ear (AHBE method), providing reproducible measurements for immediate verification of both temperature and user technique. After placement of a pulmonary artery catheter (Edwards Swan-Ganz VIP catheter, Baxter Healthcare Corporation), core temperature was measured continuously. Additional temperature probes were placed in the esophagus (Mon-a-therm general purpose, 12F, Mallinckrodt Medical Inc) and in the bladder (Thermistor-tipped urinary catheter, Medtronic Electronics Inc). Information about the method of calibration of temperature probes, the range of linearity of measurement, and the repeatability, reproducibility, and coefficient of variation of each apparatus used to monitor the temperature has been provided elsewhere.37
Potential adverse effects of hypothermia,36 such as abnormal bleeding, hemodynamic instability, arrhythmias, electrolyte disturbances, infectious diseases, and renal failure, have been recorded.
Cardiovascular Monitoring
For cardiovascular monitoring, catheters were
placed in the radial artery, the pulmonary artery, and a
central vein as soon as possible. Arterial,
pulmonary, and central venous pressure were displayed on a
multichannel monitor (HP series 600 monitor, product No. M-1166A,
Hewlett-Packard). Hemodynamic parameters,
such as cardiac output and pulmonary arterial wedge
pressure, were measured intermittently based on
hemodynamic needs but at least every 6 hours with a
Swan-Ganz catheter (Baxter Healthcare Corporation).
Simultaneously, blood gas samples were taken. Cardiac
index, systemic vascular resistance index, and pulmonary
vascular resistance index were calculated.38
Transducers (Baxter pressure monitoring kit, Bentley Laboratories
Europe BV) were positioned at the level of the midaxillary line. These
transducers were set at zero to atmosphere and calibrated against a
mercury manometer. Continuous tracings, such as ECG,
SaO2,
PETCO2, pressures, and
temperatures, were displayed on a multichannel monitor (HP series 600
monitor, Hewlett-Packard) and as analog readout (HP series No.
J11 with 8-channel analog output option, Hewlett-Packard). The analog
output function card provided 8 channels of analog output for
connection to the data acquisition system, Deweport 2000 (Dewetron
GesmbH).39 Both wave and numeric output were supported. An
interface cable that met the specifications of Hewlett-Packard
(resistance of 1 conductor <60 m
/m, capacity of 1 conductor
with other wires grounded <400 pF/m) was used. With this analog
output, the most important hemodynamic variables
were recorded. All data sampling was computer controlled, and data
processing was done on a portable workstation with integrated signal
amplifiers, 16-bit precision A/D conversion, and Pentium
microprocessor, combined in 1 instrument, and the data analysis
software Dasylab40 (version 2; Data Acquisition System;
Dasytec). Typically, the data consisted of 5-minute recordings.
All data were time correlated (time-shift correction of the
Hewlett-Packard monitor), calibrated, and simultaneously
sampled with gap-free 128 Hz on each channel to an internal high-speed
SCSI hard disk.
Neurological Evaluation
Cerebral function was assessed prospectively on arrival and at
regular intervals during the 6 months following return of spontaneous
circulation and was expressed in terms of cerebral performance
category (CPC),18 41 which is based on the Glasgow outcome
performance categories.42 The performance
categories are defined as follows: CPC 1, conscious and alert with
normal function or only slight disability; CPC 2, conscious and alert
with moderate disability; CPC 3, conscious with severe disability; CPC
4, comatose or in a persistent vegetative state; and CPC 5, certified
brain death or dead by traditional criteria. The best CPC score
achieved between 3 days and within 6 months was used for calculation. A
CPC score of 1 or 2 was considered good, whereas a CPC score of 3 or 4
was rated as poor functional neurological outcome. In agreement with
the Utstein style,18 neither long-dated neuropsychological
data, imaging data, or EEG data were used for outcome evaluation.
Statistical Analysis
According to the Utstein style, data are expressed as median and
interquartile range (IQR).18 Laboratory data and
hemodynamic parameters are measured as
median and 95% CI. A nonoverlapping of the ranges was considered
statistically significant (P value <0.05). Percentages were
determined for dichotomous variables.43
Temperature measurement in the pulmonary artery
(TP) was considered a "gold standard" and was
compared with the temperature measured in the esophagus
(TE) and the temperature measured in the urinary
bladder (TB). Agreement between the 2 methods was
assessed according to a method described by Bland and
Altmann.44 All data were computed with Microsoft Excel for
Windows, version 5.0, and SPSS for Windows, version 6.0.
| Results |
|---|
|
|
|---|
General Management
The median age of the remaining 27 patients was 58 (IQR 52 to 64)
years, with a median body surface area of 1.91 (IQR 1.86 to 2.04)
m2. Seven patients (26%) were female. In all
patients, cardiac arrest occurred out of hospital.
Bystander basic life support was performed in only 10 patients (37%). The no-flow duration was 6 (IQR 1 to 11) minutes; the low-flow duration was 15 (IQR 9 to 23) minutes. For return of spontaneous circulation, 3 (IQR 2 to 6) countershocks were needed, and the median cumulative amount of epinephrine administered intravenously during cardiopulmonary resuscitation was 6 (IQR 3 to 7) mg.
Patients arrived in the emergency department 36 (IQR 24 to 43) minutes after return of spontaneous circulation. In the emergency department, initial neurological evaluation without any sedation showed a Glasgow Coma Scale score of 3 and good respiratory (PaO2 335 [IQR 212 to 461] mm Hg) and hemodynamic (mean arterial pressure 84 [IQR 74 to 95] mm Hg) function. Eligibility was assessed within 3 minutes.
During the first 24 hours after admission, midazolam 0.2 (0.16 to 0.23) mg · kg-1 · h-1 and fentanyl 0.003 (0.003 to 0.004) mg · kg-1 · h-1 were needed, and pancuronium 0.02 (0.01 to 0.02) mg/kg was given hourly. Arterial oxygen saturation was maintained at >0.95, PaO2 between 104 (IQR 91 to 118) and 90 (IQR 80 to 102) mm Hg, and PaCO2 between 39 (IQR 35 to 41) and 34 (IQR 32 to 37) mm Hg. To maintain arterial blood pressure >60 mm Hg, crystalloids (292 [IQR 244 to 406] mL/h) were needed during the first 24 hours. Hydroxyl ethyl starch was not required. All patients had a positive fluid balance of 3280 (IQR 2160 to 4930) mL and a urine output of 167 (IQR 82 to 264) mL/h within the first 24 hours. Despite this positive fluid balance, the pulmonary arterial wedge pressure and the ratio of PaO2 to FIO2 did not show a change toward a fluid overload. Adult respiratory distress syndrome was not found in the patients who required prolonged mechanical ventilation. Epinephrine was needed in 8 patients and norepinephrine in 6; dopamine was administered in 25 patients and dobutamine in 22. Thrombolytic therapy was given to 1 patient.
Serum blood glucose was between 14.9 and 6.9 mmol/L (269 and 125
mg/dL) and hemoglobin between 144 and 120 g/L (14.4 and 12.0 g/dL)
within the cooling period (Table 1
). At admission,
arterial pH was 7.28 (IQR 7.19 to 7.35) and was maintained
between 7.42 and 7.40 until rewarming (Table 1
). Base excess
(extracellular fluid) and pH showed a tendency toward normal
values within the first 4 hours and showed stable normal values during
cooling and rewarming (Table 1
). Serum lactate decreased from
8.6 (IQR 6.5 to 11.0) mmol/L on arrival at the emergency
department to 1.6 (IQR 1.3 to 3.9) mmol/L 12 hours thereafter,
showed a further decrease during the cooling period, and was 1.6 (IQR
0.8 to 3.0) mmol/L after rewarming (Table 1
). Potassium
levels were between 3.7 and 4.2 mmol/L (Table 1
). Renal
function (creatinine and blood urea nitrogen), together
with diuresis, was not impaired (Table 1
). None of the
patients needed hemofiltration owing to oliguric renal failure.
Complications such as sepsis, coagulopathy, neutropenia, or
thrombocytopenia (Table 1
) and frostbite on the skin did not
occur in any patient.
|
There were no deaths during the time of resuscitative mild hypothermia. In 2 patients, the cooling procedure was terminated after 14 hours because of hemodynamic instability. During the hospital stay, 3 patients died of heart failure. Therapy was withdrawn in 8 patients when prognosis was considered hopeless, eg, brain death was diagnosed.
Temperature Management and Cooling Procedures
On arrival at the emergency department, the patients had a
temperature of 35.3°C (IQR 34.9°C to 36.0°C), and active cooling
was started within 5 minutes. The surface temperature of the precooled
mattress was 4°C. The target temperature was reached within 4 (IQR 3
to 5) hours after start of the external active cooling procedure.
Active cooling was performed for 24 hours. The core temperature was
>35°C within 7 hours after termination of active cooling
(Figure
).
|
The mean bias between TP and TE was 0.1°C (IQR 0.1°C to 0.2°C), the upper limit of agreement was 0.8°C, and the lower limit of agreement was -0.6°C. The mean bias between TP and TB was -0.1°C (-0.2°C to -0.1°C), the upper limit of agreement was 0.8°C, and the lower limit of agreement was -1°C.
Cardiovascular Monitoring
Arrhythmias occurred in 7 patients. There were 11 short
episodes of ventricular fibrillation and 6 of
ventricular tachycardia. In 1 of these
patients, the cooling procedure was terminated after 16 hours because
of recurrent ventricular fibrillation. Mean
arterial pressure decreased slightly, but mean
pulmonary pressure and pulmonary artery wedge pressure
did not change (Table 2
) during the first
24 hours. The initial cardiac index on arrival in the emergency
department was 2.6 (1.9 to 3.2) L ·
min-1 · m-2 and
decreased slightly within the next 4 hours during the initial cooling
period. At the end of cooling, cardiac index increased again and showed
a further increase to 3.1 (IQR 2.4 to 3.6) L ·
min-1 · m-2 at
normothermia. The systemic vascular resistance index was 2379 (1512 to
3035) dyne · s · cm-5 ·
m-2 on admission and rose within the first 4
hours of cooling. Thereafter, it decreased to 1805 (1387 to 2493)
dyne · s · cm-5 ·
m-2 and showed a further decrease in the
following rewarming period to 1460 (1164 to 1732) dyne · s
· cm-5 · m-2.
These changes were not significant, although a trend could be seen
(Table 2
).
|
Neurological Evaluation
Clinical seizures occurred in none of the patients. Fourteen
patients had a CPC score of 1 or 2, considered a good outcome, and 2
patients had a CPC score of 3 or 4, rated as a poor functional
neurological outcome. Eleven patients died before a neurological
evaluation could be performed.
| Discussion |
|---|
|
|
|---|
Surface cooling was initiated within 62 (IQR 41 to 75) minutes after cardiac arrest. The target temperature (33±1°C) was reached after 287 (IQR 242 to 401) minutes and was maintained for an additional 24 hours. Thereafter, patients were passively rewarmed and reached a temperature >35°C after 7 hours. The outcome was measured at 6 months, with the CPC score subdivided into good outcome (CPC 1 or 2), poor outcome (CPC 3 or 4), or death. After 6 months, good neurological recovery was achieved by 14 patients (52%), 2 (7%) had poor neurological recovery, and 11 (41%) died. Compared with historic controls in our department, this represents a 2-fold improvement in outcome. There were no major complications that could be directly related to treatment with mild hypothermia. Similar results were obtained by Bernard et al30 and Yanagawa et al.31 Both studies showed significant improvement in outcome in comatose survivors of out-of-hospital cardiac arrest with cooling for 12 hours30 or 48 hours.31 The latter study31 showed an increase in pneumonic complications.
To date, Benson et al32 and Williams and Spencer33 have published preliminary experience with the use of moderate resuscitative hypothermia in patients resuscitated from cardiac arrest. However, no other publications have followed these promising reports. Historic, dubious experiments during the 1940s, alternative therapies that were thought to be more effective, and concerns regarding possible complications, including arrhythmias, coagulopathy, and pulmonary infection, discouraged further experimentation or application of resuscitative hypothermia until moderate resuscitative hypothermia after cardiac arrest was evaluated in the 1980s by Gisvold et al45 in monkeys and by Leonov et al14 in dogs, showing a less impressive benefit than the subsequent series of dog studies with mild resuscitative hypothermia.15 These showed highly significant benefit in a reproducible manner.
Hypothermia is a state of body temperature below normal in a homeothermic organism. In contrast to accidental hypothermia, hypothermia used, for example, with cardiopulmonary bypass, neurosurgery, or cardiac arrest is administered in a controlled way. Hypothermia is graded into 4 levels46 : mild (34°C to 36°C), moderate (28°C to 33°C), deep (17°C to 27°C), and profound (4°C to 16°C).5
Hypothermia has been used for several years with certain surgical
procedures and circulatory arrest states. Clinical and experimental
results showed a pronounced protective effect of hypothermia during
specific ischemic states.10 11 12 It is also well
established that postischemic hypothermia reduces the
amount of cell death in certain brain regions.47 48 49 50
Recent studies have demonstrated a minimum duration and therapeutic
window of mild hypothermia of
3 hours when applied within the first
30 minutes after onset of ischemia.51 A later
start of hypothermia could also accomplish a benefit, because there is
evidence that the postischemic damage process lasts for
several days.52 53
In the last several years, various laboratory cerebral outcome studies have been performed to investigate hypothermia initiated after an ischemic state. Sterz et al15 presented a dog model of cardiac arrest in which mild hypothermia (33.3±0.6°C) initiated immediately after return of spontaneous circulation demonstrated a significant improvement in neurological outcome. In that study, the core body temperature was lowered by means of cold-water (4°C) head cooling and nasal irrigation in combination with air convection cooling by a fan and blanket. The target temperature was reached within 30 minutes after return of spontaneous circulation and was maintained for 90 minutes, with passive return to normal values 4 hours after return of spontaneous circulation. Investigating the long-term effect of delayed, postischemic mild to moderate hypothermia (24 hours with a delay of 1 hour) in a gerbil model of 5-minute forebrain ischemia, Colbourne and Corbett34 showed 70% CA1 protection compared with normothermic controls after 6 months. Although this was a significant (90%) reduction in 30-day survival, it showed for the first time a persistent, if not permanent, neuroprotection due to postischemic hypothermia. Yanamoto et al35 only saw a trend toward reduction of the infarct volume in a model of 3-hour transient focal ischemia in rats with a mild hypothermia duration of 21 hours and a delay of 30 minutes. Possibly, the ischemic time was too long to determine any benefit under hypothermic conditions. There is considerable evidence that resuscitative hypothermia has maximum benefit when applied immediately after any return of spontaneous circulation. In a study by Kuboyama et al54 using a ventricular fibrillation cardiac arrest dog model, the benefit of mild resuscitative cerebral hypothermia was diminished if not induced immediately with reperfusion after cardiac arrest. A delay of 15 minutes in initiation of cooling after reperfusion may not improve functional outcome, although it may slightly decrease tissue damage. In contrast, several other studies34 51 55 56 57 58 59 have suggested a benefit of delayed resuscitative hypothermia. Baker et al60 showed that in the setting of permanent middle cerebral artery occlusion, hypothermia markedly decreases brain injury even when its induction is delayed for up to 1 hour after the onset of ischemia.
Former and recent prospective, randomized, controlled human trials have suggested a benefit of mild resuscitative hypothermia in seriously injured patients,61 traumatic brain injury,62 63 64 65 and adult respiratory distress syndrome.66 A study on traumatic brain injury treated with mild hypothermia demonstrated an improvement of outcome at 3 and 6 months in patients with primary Glasgow Coma Scale scores of 5 to 7.67
There have been several cooling techniques suggested for clinical use, including ice bags, blankets containing circulating coolant, cold carotid artery infusions,68 single carotid artery perfusion with extracorporeally cooled blood,69 a helmet with chemical cooling capabilities,70 a cooling cap filled with -3°C solution,71 ice-water nasal lavage,72 cardiopulmonary bypass,14 and cold peritoneal lavage.73 Most of these methods are quite invasive and carry the potential of dermal injuries or other complications; therefore, we chose a rather unusual surface cooling method. We used external head cooling with a blanket Bair Hugger and systemic external cooling by means of a Blanketrol II in conjunction with a specially designed TheraKair mattress.16 17 With this setup, we could reach a target core (pulmonary artery) temperature of 33±1°C within 287 (IQR 242 to 401) minutes after cardiac arrest. This temperature was maintained for 24 hours, and the patients were passively rewarmed over another 7 hours. The TheraKair mattress had the advantage of additional kinetic therapy and thus prevented injury to the skin. This setup of cooling via blankets plus air blowing (4°C) was in the beginning the only available method to achieve the best effect of surface cooling by convection and conduction. This was rather complicated and not as effective as desired; however, it avoided an initial increase of temperature, which could have had a therapeutic effect.70 Earlier initiation of cooling would lead to a better outcome. Even so, we think it was justified to pursue delayed cooling, then let patients get warm.74 In addition, this first use of this new cooling technique should give the manufacturer the opportunity and motivation to construct a simpler cooler using noninvasive but effective cooling techniques. In the future, we will use a system of external cooling with cold air by means of a modified TheraKair mattress and body blankets supplied by a single integrated air source.
A wide variety of methods of temperature measurement (brain temperature via ventricular catheter, tympanic probe, esophageal probe, rectal probe, or Swan-Ganz catheter) are available. Brain temperature may be dissociated from systemic temperature by 0.2°C to 1°C, although differences are usually small.75 Measurement of tympanic temperature, irrespective of brain temperature, has the advantage of being noninvasive, fast, and easily applicable and therefore has been used routinely to fulfill the eligibility criteria. Because the purpose of this trial was to investigate the effect of mild resuscitative hypothermia, no major effort was made to compare different temperature-monitoring methods. As soon as possible, Swan-Ganz catheter measurements were taken instead of tympanic temperature, because they are more reliable under surface cooling conditions. In addition, we showed that the temperature course at different body sites (pulmonary artery, esophagus, and bladder) showed no major differences.
There are concerns about potential adverse effects of hypothermia.37 There have been reports of an association between hypothermia, trauma, and abnormal bleeding.76 Hypothermia prolongs prothrombin and partial thromboplastin times77 and also has an adverse effect on platelet function.78 In the present study, no significant bleeding complications and no influence on major coagulation parameters due to mild resuscitative hypothermia were found. One patient excluded from analysis was found to have liver rupture due to traumatic injury within the scope of incorrect external chest compressions performed during basic life support by bystanders. Another patient, who received thrombolytic therapy, developed small hematomas on the right upper extremity due to numerous unsuccessful venipuncture attempts.
The impact of hypothermia on the cardiovascular system
is discussed controversially. There are concerns that resuscitative
hypothermia may cause hemodynamic instability after
resuscitation from cardiac arrest, because many of these patients have
myocardial ischemia. Sinus bradycardia is common; however,
junctional bradycardia and atrial fibrillation with a slow
ventricular response rate may be seen when the temperature
drops to 30°C. Ventricular irritability and fibrillation
are increasingly common below 25°C to 28°C.5 79 80
However, if the core temperature is kept above 30°C, there is little
risk of significant bradycardia or ventricular fibrillation
due to hypothermia.81 In 1 of our patients with malignant
arrhythmias, the attending physician decided to stop cooling
after 16 hours. However, the patient continued to have arrhythmogenic
hemodynamic instability after normothermia had been
achieved. Hypokalemia, which commonly occurs as core temperature
decreases, results from the movement of potassium into cells and may
worsen the arrhythmogenic effect.82 However, hypokalemia
was not seen in our patients. Cardiac contractility,
measured in a variety of ways, increases until temperature reaches
25°C.79 Thus, stroke volume may increase and cardiac
output may be maintained.83 On the other hand, some have
reported decreased ejection fraction and cardiac output, particularly
with hypothermic times of 10 to 24 hours or more.84
Because of an increase in systemic vascular
resistance,36 85 blood pressure is little affected. It was
not necessary to stop cooling because of hemodynamic
effects of mild resuscitative hypothermia in any of our patients.
Several authors have commented on an increased incidence of
neutropenia, septicemia, and pneumonia in children with anoxic brain
injury after near drowning86 and in head-injured patients
treated with hypothermia.87 This may reflect inhibition of
neutrophile release or other factors.88 None of our
patients developed infectious diseases, eg, sepsis syndrome. Moderate
hypothermia is known to increase urine output despite decreased renal
blood flow, due to decreased solute reabsorption.89 In all
of our patients, we observed an increased need for volume replacement
due to high urinary output during the cooling period.
In conclusion, mild resuscitative hypothermia in patients after cardiac arrest is feasible, and it is expected that a clinical multicenter trial will prove that it may be a useful method of cerebral resuscitation after global ischemic states and therefore promote the prevention of neuromental diseases.
| Acknowledgments |
|---|
| Footnotes |
|---|
This work was presented at the Society of Critical Care Medicine 25th Educational & Scientific Symposium, New Orleans, La, February 59, 1996, and the 69th Scientific Sessions of the American Heart Association, New Orleans, La, November 1013, 1996, and was previously published in abstract form (Crit Care Med. 1996;24:A115 and Circulation. 1996;94[suppl I]I-9I-10.).
| Appendix 1 |
|---|
|
|
|---|
Received June 18, 1999; revision received August 24, 1999; accepted October 26, 1999.
| References |
|---|
|
|
|---|
2. Negovsky VA. Postresuscitation disease. Crit Care Med. 1988;16:942946.[Medline] [Order article via Infotrieve]
3. Safar P. Resuscitation from clinical death: pathophysiologic limits and therapeutic potentials. Crit Care Med. 1988;16:923941.[Medline] [Order article via Infotrieve]
4. Sterz F, Zeiner A, Kürkciyan I, Janata K, Müllner M, Domanovits H, Safar P. Mild resuscitative hypothermia and outcome after cardiopulmonary resuscitation. J Neurosurg Anesthesiol. 1996;8:8896.[Medline] [Order article via Infotrieve]
5. Reuler JB. Hypothermia: pathophysiology, clinical settings and management. Ann Intern Med. 1978;99:519527.
6.
Danzl DF, Pozos RS. Accidental hypothermia.
N Engl J Med. 1994;331:17561760.
7.
Young RSK, Zalneraitis EL, Dooling EC. Neurologic
outcome in cold water drowning. JAMA. 1980;244:12331239.
8.
Sekar TS, MacDonnel KF, Namsirikul P, Herman RS.
Survival after prolonged submersion in cold water without neurologic
sequelae. Arch Intern Med. 1980;140:775776.
9. Althaus N. Management of profound accidental hypothermia with cardiorespiratory arrest. Ann Surg. 1982;195:492495.[Medline] [Order article via Infotrieve]
10. Bigelow WG, Lindsay WK, Greenwood WF. Hypothermia: its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann Surg. 1950;132:849866.[Medline] [Order article via Infotrieve]
11. Rosomoff HL. Protective effects of hypothermia against pathological processes of the nervous system. Ann N Y Acad Sci. 1959;80:475486.
12. Rosomoff HL, Holaday DA. Cerebral blood flow and cerebral oxygen consumption during hypothermia. Am J Physiol. 1954;179:8588.
13.
Swain JA. Cardiac surgery and the brain. N
Engl J Med. 1993;329:11191120.
14. Leonov Y, Sterz F, Safar P, Radovsky A, Oku K, Tisherman S, Stezoski SW. Mild cerebral hypothermia during and after cardiac arrest improves neurologic outcome in dogs. J Cereb Blood Flow Metab. 1990;10:5770.[Medline] [Order article via Infotrieve]
15. Sterz F, Safar P, Tisherman S, Radovsky A, Kuboyama K, Oku K. Mild hypothermic cardiopulmonary resuscitation improves outcome after prolonged cardiac arrest in dogs. Crit Care Med. 1991;19:379389.[Medline] [Order article via Infotrieve]
16. Zeiner A, Müllner M, Sterz F, Frossard M, Laggner AN. Mild resuscitative therapeutic hypothermia after cardiac arrest and its influence on hemodynamic parameters. Crit Care Med. 1996;24:A115. Abstract.
17. Zeiner A, Muellner M, Frossard M, Janata K, Behringer W, Holzer M, Sterz F, Laggner AN. Mild therapeutic hypothermia to improve neurologic outcome after cardiac arrest: a pilot study. Circulation. 1996;94(suppl I):I-9I-10. Abstract.
18.
American Heart Association Medical/Scientific
Statement. Recommended guidelines for uniform reporting of data from
out-of-hospital cardiac arrest: the Utstein style.
Circulation. 1991;84:960975.
19. Eisenberg MS, Cummins RO, Damon S, Larsen MP, Hearne TR. Survival rates from out-of-hospital cardiac arrest: recommendations for uniform definitions and data to report. Ann Emerg Med. 1990;19:12491259.[Medline] [Order article via Infotrieve]
20. Becker LB, Ostrander MP, Barrett J, Kondos GT. Outcome of CPR in a large metropolitan area: where are the survivors? Ann Emerg Med. 1991;20:355361.[Medline] [Order article via Infotrieve]
21. Pepe PE, Levine RL, Fromm RE, Curka PA, Clark PS, Zachariah BS. Cardiac arrest presenting with rhythms other than ventricular fibrillation: contribution of resuscitative efforts toward total survivorship. Crit Care Med. 1993;21:18381843.[Medline] [Order article via Infotrieve]
22. Beer RJ, Teasdale TA, Ghusn HF, Taffet GE. Estimation of severity of illness with APACHE II: age-related implications in cardiac arrest outcomes. Resuscitation. 1994;27:189195.[Medline] [Order article via Infotrieve]
23.
Hallstrom AP, Copp LA, Yu BH. Influence of comorbidity
on the outcome of patients treated for out-of-hospital
ventricular fibrillation. Circulation. 1996;93:20192022.
24. Mullie A, Lewi P, Van Hoeyweghen R. Pre-CPR conditions and the final outcome of CPR: the Cerebral Resuscitation group. Resuscitation. 1989;17:S11S21.
25. Laborit H, Huguenard P. Lhibernation artificielle par moyens pharmacodynamiques et physiques en chirurgie. J Chir. 1951;67:631641.
26. Vandam LD, Burnap TK. Medical progress: hypothermia. N Engl J Med. 1959;261:546553.
27. Singer D. Bretschneider H. Metabolic reduction in hypothermia: pathophysiological and natural examples: part 2. Thorac Cardiovasc Surg. 1990;38:212219.[Medline] [Order article via Infotrieve]
28. Brengelmann GL. Body temperature regulation. In: Patton HD, Fuchs AF, Hille B, Scher AM, Steiner R, eds. Textbook of Physiology. 21st ed. Philadelphia, Pa: WB Saunders Co; 1989:15841596.
29. Betschart M. The diagnosis of brain death: guidelines in Germany, Austria and Switzerland. Anaesthesist. 1993;42:259269.[Medline] [Order article via Infotrieve]
30. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med. 1997;30:146153.[Medline] [Order article via Infotrieve]
31. Yanagawa Y, Ishihara S, Norio H, Takino M, Kawakami M, Takasu A, Okamoto K, Kaneko N, Terai C, Okada Y. Preliminary clinical outcome study of mild resuscitative hypothermia after out-of-hospital cardiopulmonary arrest. Resuscitation. 1998;39:6166.[Medline] [Order article via Infotrieve]
32. Benson DW, Williams GR, Spencer FC. The use of hypothermia after cardiac arrest. Anesth Analg. 1958;38:423428.
33. Williams GR Jr, Spencer FC. Clinical use of hypothermia following cardiac arrest. Ann Surg. 1959;148:462468.
34. Colbourne F, Corbett D. Delayed postischemic hypothermia: a six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci. 1995;15:72507260.[Abstract]
35. Yanamoto H, Hong SC, Soleau S, Kassell NF, Lee KS. Mild postischemic hypothermia limits cerebral injury following transient focal ischemia in rat neocortex. Brain Res. 1996;718:207211.[Medline] [Order article via Infotrieve]
36. Rupp SM, Severinghaus JW. Hypothermia. In: Miller RD, ed. Anesthesia. 2nd ed. New York, NY: Churchill Livingstone; 1986:19952022.
37. Pompei MA, Pompei F. Physician Reference Handbook on Temperature. Watertown, Mass: Exergen Corp; 1996.
38.
Shoemaker WC, Montgomery ES, Kaplan ES, Elwyn DH.
Physiological patterns in surviving and
non-surviving patients: use of sequential cardiorespiratory
variables in defining criteria for therapeutic goals and early
warnings of death. Arch Surg. 1973;106:630636.
39. Gerl H. Deweport 2000TM: die Kompaktloesung. Elektronik Schau. 1994;10:1923.
40. Stephan M. Dasylab das komplette Meßlabor. Elektronik Aktuell Industriell. 1995;5:610.
41. Brain Resuscitation Clinical Trial I Study Group. A randomized clinical study of cardiopulmonary-cerebral resuscitation: design, methods, and patient characteristics. Am J Emerg Med. 1986;4:7286.[Medline] [Order article via Infotrieve]
42. Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;1:480484.[Medline] [Order article via Infotrieve]
43. Altman DG. Practical Statistics for Medical Research. 1st ed. London, UK: Chapman & Hall; 1991.
44. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1968;8:307310.
45.
Gisvold SE, Safar P, Rao G, Moossy J, Kelsey S,
Alexander H. Multifaceted therapy after global brain ischemia
in monkeys. Stroke. 1984;15:803812.
46. Hitchcock C, Strobel C, Haglin J, Wilson J. Use of prolonged moderate hypothermia in postoperative care. Arch Surg. 1962;85:549556.
47.
Chopp M, Chen H, Dereski MO, Garcia JH. Mild
hypothermic intervention after graded ischemic stress in rats.
Stroke. 1991;22:3743.
48. Busto R, Dietrich WD, Globus MY, Ginsberg MD. Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury. Neurosci Lett. 1989;101:299304.[Medline] [Order article via Infotrieve]
49. Inglefield JR, Perry JM, Schwartz RD. Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus. Hippocampus. 1995;5:460468.[Medline] [Order article via Infotrieve]
50. Siemkowicz E, Haider A. Post-ischemic hypothermia ameliorates ischemic brain damage but not post-ischemic audiogenic seizures in rats. Resuscitation. 1995;30:6167.[Medline] [Order article via Infotrieve]
51. Markarian GZ, Lee JH, Stein DJ, Hong SC. Mild hypothermia: therapeutic window after experimental cerebral ischemia. Neurosurgery. 1996;38:542550.[Medline] [Order article via Infotrieve]
52. Sirimanne ES, Blumberg RM, Bossano D, Gunning M, Edwards AD, Gluckman PD, Williams CE. The effect of prolonged modification of cerebral temperature on outcome after hypoxic-ischemic brain injury in the infant rat. Pediatr Res. 1996;39:591597.[Medline] [Order article via Infotrieve]
53. Green EJ, Pazos AJ, Dietrich WD, McCabe PM, Schneiderman N, Lin B, Busto R, Globus MY, Ginsberg MD. Combined postischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats. Brain Res. 1995;702:145152.[Medline] [Order article via Infotrieve]
54. Kuboyama K, Safar P, Radovsky A, Tisherman SA, Stezoski SW, Alexander H. Delay in cooling negates the beneficial effect of mild resuscitative cerebral hypothermia after cardiac arrest in dogs: a prospective, randomized study. Crit Care Med. 1993;21:13481358.[Medline] [Order article via Infotrieve]
55. Colbourne F, Corbett D. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil. Brain Res. 194;654:265272.
56. Coimbra C, Wieloch T. Hypothermia ameliorates neuronal survival when induced 2 hours after ischemia in the rat. Acta Physiol Scand. 1992;146:543544.[Medline] [Order article via Infotrieve]
57. Horn M, Schlote W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol. 1992;85:7987.[Medline] [Order article via Infotrieve]
58. Karibe H, Chen J, Zarow GJ, Graham SH, Weinstein PR. Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats. J Neurosurg. 1994;80;112119.
59. Xue D, Huang ZG, Smith KE, Buchan AM. Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Res. 1992;587:6672.[Medline] [Order article via Infotrieve]
60. Baker CJ, Onesti ST, Solomon RA. Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study. J Neurosurg. 1992;77:438444.[Medline] [Order article via Infotrieve]
61. Luna GK, Maier RV, Pavlin EG, Anardi D, Copass MK, Oreskovich MR. Incidence and effect of hypothermia in seriously injured patients. J Trauma. 1987;27:10141018.[Medline] [Order article via Infotrieve]
62. Fay T. Observations on generalized refrigeration in cases of severe cerebral trauma. Res Publ Ass Nerv Dis. 1945;4:611619.
63. Marion DW, Obrist WD, Carlier PM, Penrod LE, Darby JM. The use of moderate therapeutic hypothermia for patients with severe head injuries. J Neurosurg. 1993;79:354362.[Medline] [Order article via Infotrieve]
64. Shiozaki TS, Sugimoto H, Taneda M, Yoshida H, Iwai A, Yoshioha T, Sugimoto T. Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury. J Neurosurg. 1993;79:363367.[Medline] [Order article via Infotrieve]
65. Clifton GL, Allen S, Barrodale P, Plenger P, Berry J, Koch S, Fletcher J, Hayes RL, Choi SC. A phase 1 study of moderate hypothermia in severe brain injury. J Neurotrauma. 1993;10:263271.[Medline] [Order article via Infotrieve]
66. Villar J, Slutsky AS. Effects of induced hypothermia in patients with septic adult respiratory distress syndrome. Resuscitation. 1993;26:183192.[Medline] [Order article via Infotrieve]
67.
Marion DW, Penrod LE, Kelsey SF, Obrist WD, Kochanek
PM, Palmer AM, Wisniewski SR, DeKosky ST. Treatment of traumatic brain
injury with moderate hypothermia. N Engl J Med. 1997;336:540546.
68. Connolly J, Boyd R, Calvin J. The protective effect of hypothermia in cerebral ischemia: experimental and clinical application by selective brain cooling in the human. Surgery. 1962;52:1524.[Medline] [Order article via Infotrieve]
69. Schwartz AE, Stone JG, Finck AD, Sandhu AA, Mongero LB, Adams DC, Jonassen AE, Young WL, Michler RE. Isolated cerebral hypothermia by single carotid artery perfusion of extracorporeally cooled blood in baboons. Neurosurgery. 1996;39:577581.[Medline] [Order article via Infotrieve]
70. Brader EW. Cerebral preservation during cardiac arrest. Am J Emerg Med. 1988;6:151156.[Medline] [Order article via Infotrieve]
71. Gelman B, Schleien CL, Lohe A, Kuluz JW. Selective brain cooling in infant piglets after cardiac arrest and resuscitation. Crit Care Med. 1996;24:10091017.[Medline] [Order article via Infotrieve]
72.
Natale JA, DAlecy LG. Protection from cerebral
ischemia by brain cooling without reduced lactate accumulation
in dogs. Stroke. 1989;20:770777.
73. Xiao F, Safar P, Alexander H. Peritoneal cooling for mild cerebral hypothermia after cardiac arrest in dogs. Resuscitation. 1995;30:5159.[Medline] [Order article via Infotrieve]
74. Reith J, Jørgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422425.[Medline] [Order article via Infotrieve]
75.
Safar P, Xiao F, Radovsky A, Tanigawa K, Ebmeyer U,
Bircher N, Alexander H, Stezoski SW. Improved cerebral resuscitation
from cardiac arrest in dogs with mild hypothermia plus blood flow
promotion. Stroke. 1996;27:105113.
76. Patt A, McCroskey BL, More EE. Hypothermia induced coagulopathies in trauma. Surg Clin North Am. 1988;68:775785.[Medline] [Order article via Infotrieve]
77. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med. 1992;20:14021405.[Medline] [Order article via Infotrieve]
78. Valerie CR, Feingold H, Cassidy G, Ragno G, Khuri S, Altschule MD. Hypothermia induced platelet dysfunction. Ann Surg. 1987;205:175181.[Medline] [Order article via Infotrieve]
79. Badeer HS. Effect of hypothermia on the contractile capacity of the myocardium. J Thorac Cardiovasc Surg. 1967;53:651656.[Medline] [Order article via Infotrieve]
80. Mouritzen CV, Andersen MN. Mechanisms of ventricular fibrillation during hypothermia: relative changes in myocardial refractory period and conduction velocity. J Thorac Cardiovasc Surg. 1966;51:585589.
81. Danzl DF, Pozos RS. Accidental hypothermia. N Engl J Med. 1994;331:17561760.
82. Sprung J. Effects of acute hypothermia and beta-adrenergic receptor blockade on serum potassium concentration in rats. Crit Care Med. 1991;19:15451551.[Medline] [Order article via Infotrieve]
83. Meyer DM, Horton JW. Effect of different degrees of hypothermia on myocardium in treatment of hemorrhagic shock. J Surg Res. 1990;48:6167.[Medline] [Order article via Infotrieve]
84. Steen PA, Milde JH, Michenfelder JD. The detrimental effects of prolonged hypothermia and rewarming in the dog. Anesthesiology. 1980;52:224230.[Medline] [Order article via Infotrieve]
85. Wong KC. Physiology and pharmacology of hypothermia. West J Med. 1983;138:227232.[Medline] [Order article via Infotrieve]
86. Bohn DJ, Biggar WD, Smith CR, Conn AW, Barker GA. Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near drowning. Crit Care Med. 1986;14:529534.[Medline] [Order article via Infotrieve]
87. Darke CG, Jory TA. Hypothermia in the treatment of critical head injury. Can Med J. 1962;87:887891.
88.
Biggar WD, Bohn D, Kent G. Neutrophile circulation and
release from bone marrow during hypothermia. Infect Immun. 1983;40:708712.
89. Delin A. Regional blood flow in hypothermia. J Thorac Cardiovasc Surg. 1958;22:514517.
This article has been cited by other articles:
![]() |
A. Schneider, B. W. Bottiger, and E. Popp Cerebral Resuscitation After Cardiocirculatory Arrest Anesth. Analg., March 1, 2009; 108(3): 971 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Varon and P. Acosta Therapeutic Hypothermia: Past, Present, and Future Chest, May 1, 2008; 133(5): 1267 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kimme, S. Fridrikssen, O. Engdahl, J. Hillman, M. Vegfors, and F. Sjoberg Moderate hypothermia for 359 operations to clip cerebral aneurysms Br. J. Anaesth., September 1, 2004; 93(3): 343 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Abella, D. Zhao, J. Alvarado, K. Hamann, T. L. Vanden Hoek, and L. B. Becker Intra-Arrest Cooling Improves Outcomes in a Murine Cardiac Arrest Model Circulation, June 8, 2004; 109(22): 2786 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.P. Nolan, P.T. Morley, T.L. Vanden Hoek, R.W. Hickey, W.G.J. Kloeck, J. Billi, B.W. Bottiger, P.T. Morley, J.P. Nolan, K. Okada, et al. Therapeutic Hypothermia After Cardiac Arrest: An Advisory Statement by the Advanced Life Support Task Force of the International Liaison Committee on Resuscitation Circulation, July 8, 2003; 108(1): 118 - 121. [Full Text] [PDF] |
||||
![]() |
L. B. Becker, M. L. Weisfeldt, M. H. Weil, T. Budinger, J. Carrico, K. Kern, G. Nichol, I. Shechter, R. Traystman, C. Webb, et al. The PULSE Initiative: Scientific Priorities and Strategic Planning for Resuscitation Research and Life Saving Therapies Circulation, May 28, 2002; 105(21): 2562 - 2570. [Full Text] [PDF] |
||||
![]() |
M. S. Wainwright, H. Sheng, Y. Sato, G. Burkhard Mackensen, R. P. Steffen, R. D. Pearlstein, and D. S. Warner Pharmacological correction of hypothermic P50 shift does not alter outcome from focal cerebral ischemia in rats Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1863 - H1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Hypothermia after Cardiac Arrest Study Group Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest N. Engl. J. Med., February 21, 2002; 346(8): 549 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Bernard, T. W. Gray, M. D. Buist, B. M. Jones, W. Silvester, G. Gutteridge, and K. Smith Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia N. Engl. J. Med., February 21, 2002; 346(8): 557 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Georgiadis, S. Schwarz, R. Kollmar, and S. Schwab Endovascular Cooling for Moderate Hypothermia in Patients With Acute Stroke: First Results of a Novel Approach Stroke, November 1, 2001; 32(11): 2550 - 2553. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Felberg, D. W. Krieger, R. Chuang, D. E. Persse, W. S. Burgin, S. L. Hickenbottom, L. B. Morgenstern, O. Rosales, and J. C. Grotta Hypothermia After Cardiac Arrest: Feasibility and Safety of an External Cooling Protocol Circulation, October 9, 2001; 104(15): 1799 - 1804. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zeiner, M. Holzer, F. Sterz, W. Schorkhuber, P. Eisenburger, C. Havel, A. Kliegel, and A. N. Laggner Hyperthermia After Cardiac Arrest Is Associated With an Unfavorable Neurologic Outcome Arch Intern Med, September 10, 2001; 161(16): 2007 - 2012. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Krieger, M. A. De Georgia, A. Abou-Chebl, J. C. Andrefsky, C. A. Sila, I. L. Katzan, M. R. Mayberg, and A. J. Furlan Cooling for Acute Ischemic Brain Damage (COOL AID): An Open Pilot Study of Induced Hypothermia in Acute Ischemic Stroke Stroke, August 1, 2001; 32(8): 1847 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.P. Kammersgaard, B.H. Rasmussen, H.S. Jorgensen, J. Reith, U. Weber, and T.S. Olsen Feasibility and Safety of Inducing Modest Hypothermia in Awake Patients With Acute Stroke Through Surface Cooling: A Case-Control Study : The Copenhagen Stroke Study Stroke, September 1, 2000; 31(9): 2251 - 2256. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |